Common birth control shot linked to risk of HIV infection

January 4, 2018, The Endocrine Society
Zdenek Hel. Credit: UAB

Transitioning away from a popular contraceptive shot known as DMPA could help protect women in Sub-Saharan Africa and other high-risk regions from becoming infected with HIV, according to a research review published in the Endocrine Society's journal Endocrine Reviews.

The predominant contraceptive in Sub-Saharan Africa is depot-medroxyprogesterone acetate (DMPA)—a shot administered every three months. Human studies suggest DMPA use may raise the risk of HIV infection by 40 percent. Other forms of contraceptive shots do not show the same correlation with HIV infection. In this article, the authors review the underlying biological mechanisms that could contribute to increased risk of HIV infection for certain hormonal contraceptives but not others.

According to UNAIDS, 36.7 million people worldwide were living with HIV as of 2016. AIDS is the most advanced stage of HIV infection.

"To protect individual and public health, it is important to ensure women in areas with high rates of HIV infection have access to affordable contraceptive options," said the review's first author, Prof. Janet P. Hapgood, Ph.D., of the University of Cape Town in Cape Town, South Africa. "Increasing availability of contraceptives that use a different form of the female hormone progestin than the one found in DMPA could help reduce the risk of HIV transmission."

In addition to these clinical studies, the review's authors examined animal, cell and biochemical research on the form of progestin used in DMPA—medroxprogesterone acetate, or MPA. The analysis revealed MPA acts differently than other forms of progestin used in contraceptives. MPA behaves like the in the cells of the that can come in contact with HIV.

"The increased rate of HIV infection among women using DMPA contraceptive shots is likely due to multiple reasons, including decreases in immune function and the protective barrier function of the female genital tract," Hapgood said. "Studying the biology of MPA helps us understand what may be driving the increased rate of HIV infection seen in human research. These findings suggest other forms of birth control should rapidly replace DMPA shots."

Explore further: Risk of HIV infection in studies of African women using hormonal contraceptives

More information: Hormonal Contraception and HIV-1 Acquisition: Biological Mechanisms, Endocrine Reviews, academic.oup.com/edrv/advance- … r.2017-00103/4788769

Related Stories

Risk of HIV infection in studies of African women using hormonal contraceptives

January 22, 2015
Use of the injectable progestin contraceptive depot-medroxyprogesterone acetate (DMPA) is linked to an increased risk for HIV infection, according to an article published by Charles Morrison of FHI 360 and colleagues in this ...

Why do certain hormonal contraceptives increase the risk of HIV?

September 1, 2015
In recent years, evidence has been building that injectable contraceptive depot medroxyprogesterone acetate (Depo-Provera or DMPA) is associated with an increased risk of HIV infection. Now a study published in the September ...

Study finds link between injectable contraceptives and breast cancer risk in younger women

April 4, 2012
The first large-scale U.S.-based study to evaluate the link between an injectable form of progestin-only birth control and breast cancer risk in young women has found that recent use of a year or more doubles the risk. The ...

Study supports link between injectable hormonal contraceptive and HIV risk

January 9, 2015
Women using depot medroxyprogesterone acetate (DMPA), commonly known as Depo-Provera or the birth control shot, have a moderately increased risk of becoming infected with HIV, a large meta-analysis of 12 studies involving ...

Injectable progesterone contraceptives may be associated with poor periodontal health

February 6, 2012
Injectable progesterone contraceptives may be associated with poor periodontal health, according to research in the Journal of Periodontology. The study found that women who are currently taking depotmedroxyprogesterone acetate ...

Recommended for you

Risks to babies of mothers with HIV from three antiretroviral regimens appear to be low

April 25, 2018
The risk for preterm birth and early infant death is similar for three antiretroviral drug regimens taken by pregnant women with HIV according to a new study from Harvard T.H. Chan School of Public Health.

Inducing labor at 39 weeks reduces risks of C-section and other complications

April 25, 2018
It's better to induce than to watch and wait. That's the result of a new study published in PLOS ONE.

New method allows scientists to study how HIV persists

April 24, 2018
After 35 years of rigorous research, there is still no cure for HIV. Current drugs can be used to halt the infection, but fall short of reaching hidden reserves of dormant virus that can lurk for life within infected white ...

Prolonged acetaminophen use during pregnancy linked to increased ASD and ADHD risk

April 24, 2018
A study from the Hebrew University of Jerusalem sheds new light on the possible relationship between prolonged use of acetaminophen (paracetamol) during pregnancy and the risk of neurodevelopmental disorders in childhood.

HIV-1 viruses transmitted at birth are resistant to antibodies in mother's blood

April 19, 2018
Of the genetically diverse population of HIV-1 viruses present in an infected pregnant woman, the few she might transmit to her child during delivery are resistant to attack by antibodies in her blood, according to new research ...

Top HIV cure research team refutes major recent results on how to identify HIV persistence

April 18, 2018
An international team focused on HIV cure research spearheaded by The Wistar Institute in collaboration with the University of Pennsylvania and Vall d'Hebron Research Institute (VHIR) in Barcelona, Spain, established that ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.